Brind.

KALA BIO, Inc. received Orphan Drug and Fast Track designations from the Food and Drug Administration on September 3, 2025.

3 reports, 1 independent Updated Sep 3

Gone quiet

Reports: 3
Developments: 2
Repetition: 33%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

KALA BIO, Inc. received Orphan Drug and Fast Track designations from the Food and Drug Administration on September 3, 2025.

Who's involved

What this event is mainly about

KALA BIO, Inc.Food and Drug Administration

How it developed

Newest first. Tap a step to see who reported it.

Sep 3KALA BIO, Inc. received Orphan Drug and Fast Track designations from the FDA.1 source
- GlobeNewswire
Jul 9KALA BIO, Inc. seeks BLA approval from the FDA for KPI-012.

Keep exploring

The entities involved

KALA BIO, Inc.
Czech company

Nothing else this week.
Food and Drug Administration
government organization in Nonthaburi, Thailand
- Trump is expected to nominate Heidi Overton to lead the Food and Drug Administration.Mon 15:49
- In 2007, CBS broadcast featured Andrews, Cordes, and Couric criticizing the Food and Drug Administration's problems.Mon 12:46

Coverage

Newest first; wire copies grouped

Sep 3GlobeNewswireKALA BIO to Present at H.C. Wainwright 27th Annual Global Investment Conference ARLINGTON, Mass., Sept. 03, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical c
Aug 6GlobeNewswireKALA BIO to Present at H.C. Wainwright 5th Annual Ophthalmology Virtual Conference ARLINGTON, Mass., Aug. 06, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical
Jul 9Unknown outlet